Strides Pharma Science informs about press release

15 Jan 2021 Evaluate

Strides Pharma Science has informed that it has attached Press Release on 15th January 2021, titled ‘Strides receives USFDA approval for Emtricitabine and Tenofovir Disoproxil Fumarate Tablets’.

The above information is a part of company’s filings submitted to BSE.



Strides Pharma Scien Share Price

847.75 3.70 (0.44%)
19-Apr-2024 11:57 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1505.80
Dr. Reddys Lab 5901.00
Cipla 1351.00
Zydus Lifesciences 922.90
Lupin 1564.60
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.